1974 - 1978 B.S., University of Kansas, Lawrence, Kansas
1978 - 1982 M.D., University of Kansas, Kansas City, Kansas
Dr. Linenberger has led the local institutional practices, policies and procedures to ensure the safe procurement of blood marrow cells from healthy donors and from patients with a variety of diseases. Dr. Linenberger supervised the in vitro manipulation, cryopreservation and administration of cells and processed in our GTP laboratory. He has been involved in the planning, implementation and quality oversight of IND and other experimental protocols that utilize our GMP laboratory. Dr. Linenberger has participated in national standards committees, applications and governance committees and working groups of AABB and ASFA, which established policies for cellular therapy, apheresis and donor safety. He has directed and participated in research protocols studying stem cell donor safety and adverse events related to stem cell infusions. Other interests of Dr. Linenberger include optimization of methods for stem cell procurement, therapeutic apheresis approaches for post-transplant graft-versus-host disease, and cellular therapy applications relevant to hematopoietic stem cell transplantation.
Marrow and peripheral blood stem cell procurement;
Iron overload disorders;
Benign and malignant hematologic disorders.
A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
Cancer Center Support Grant
Adult Leukemia Research Center